Cooley advised ERYTECH Pharma on a private placement of its ordinary shares to qualified investors in the US and Europe. Total gross proceeds to ERYTECH were…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
